Course Overview

Treatment of esophageal cancers generally requires a multifaceted approach. The advent of immunotherapy checkpoint inhibitors in recent years is a welcome development for patients, but their existence complicates clinicians’ efforts to select and sequence treatments.

This activity organizes and presents key treatment information in a digital, interactive infographic format. This design facilitates a high degree of personalization by allowing you to explore topics most aligned with your personal interests and needs.



Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
  • Nurses — 0.5 Contact Hours
  • Physician Assistants — 0.5 AAPA Category 1 CME credit

Yelena Janjigian
Yelena Janjigian, MD

Associate Professor and Chief of Gastroenterology Oncology Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY